Strides Pharma Science announced that its 50:50 JV Strides Vivimed Pte., Singapore has received approval for Albendazole Tablets USP 200 mg from the United States Food & Drug Administration (US FDA). This is the
second generic approval by US FDA for Albendazole Tablets.
Albendazole Tablets is a generic version of Albenza Tablets of Amneal Pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately US$ 100 Mn.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
